In patients with glutaric acidemia type 1 (GAI), biochemical and molecular markers fail to predict the course of individual patients; therefore we sought to identify nonbiochemical variables that correlate with severity of motor deficits or overall clinical outcome.
Division of Clinical Pharmacology and Toxicology, the Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
